University of Michigan

University / College


Location: Ann Arbor, MI, United States (USA) (US) US

ISNI: 0000000086837370

ROR: https://ror.org/00jmfr291

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Supporting the Transition to Climate-Neutral Production: An Evaluation Under the Agreement on Subsidies and Countervailing Measures (2023) Ismer R, van Asselt H, Haverkamp J, Mehling M, Neuhoff K, Pirlot A Journal article Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes : A Mediation Analysis. (2023) Agarwal R, Tu W, Farjat AE, Farag YM, Toto R, Kaul S, Lawatscheck R, et al. Journal article The High Energy X-ray Probe (HEX-P): probing accretion onto stellar mass black holes (2023) Connors RM, Tomsick JA, Draghis P, Coughenour B, Shaw AW, García JA, Walton D, et al. Journal article Overview of the Advanced X-ray Imaging Satellite (AXIS) (2023) Reynolds CS, Kara EA, Mushotzky RF, Ptak A, Koss MJ, Williams BJ, Allen SW, et al. Conference contribution Guidelines for neuroprognostication in adults with traumatic spinal cord injury (2023) Mahanes D, Muehlschlegel S, Wartenberg KE, Rajajee V, Alexander SA, Busl KM, Creutzfeldt CJ, et al. Journal article Guidelines for Neuroprognostication in Critically Ill Adults with Intracerebral Hemorrhage (2023) Hwang DY, Kim KS, Muehlschlegel S, Wartenberg KE, Rajajee V, Alexander SA, Busl KM, et al. Journal article Author Correction: Guidelines for Neuroprognostication in Adults with Guillain–Barré Syndrome (Neurocritical Care, (2023), 38, 3, (564-583), 10.1007/s12028-023-01707-3) (2023) Busl KM, Fried H, Muehlschlegel S, Wartenberg KE, Rajajee V, Alexander SA, Creutzfeldt CJ, et al. Journal article, Erratum Correction to: Guidelines for Neuroprognostication in Adults with Guillain–Barré Syndrome (Neurocritical Care, (2023), 10.1007/s12028-023-01707-3) (2023) Busl KM, Fried H, Muehlschlegel S, Wartenberg KE, Rajajee V, Alexander SA, Creutzfeldt CJ, et al. Journal article, Erratum Effects of oral semaglutide on cardiovascular outcomes in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or chronic kidney disease: Design and baseline characteristics of SOUL, a randomized trial (2023) McGuire DK, Busui RP, Deanfield J, Inzucchi SE, Mann JF, Marx N, Mulvagh SL, et al. Journal article Guidelines for Neuroprognostication in Adults with Guillain–Barré Syndrome (2023) Busl KM, Fried H, Muehlschlegel S, Wartenberg KE, Rajajee V, Alexander SA, Creutzfeldt CJ, et al. Journal article